Small Cell Lung Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Condition: Small Cell Lung Cancer Interventions: Drug: SC0245; Drug: Irinotecan Sponsor: Biocity Biopharmaceutics Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2023 Category: Research Source Type: clinical trials
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
Conditions: SCLC,Extensive Stage; SLFN11-positive Intervention: Drug: Niraparib Sponsors: ETOP IBCSG Partners Foundation; GlaxoSmithKline; Development Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials
